Cargando…
Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study
Multi-systemic biological risk (MSBR), a proxy for allostatic load, is a composite index of biomarkers representing dysregulation due to responses to chronic stress. This study examined the association of an MSBR index with cancer mortality. The sample included n = 13,628 adults aged 20–90 from the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081240/ https://www.ncbi.nlm.nih.gov/pubmed/32193496 http://dx.doi.org/10.1038/s41598-020-61945-9 |
_version_ | 1783508136776171520 |
---|---|
author | Acheampong, Teofilia Jiang, Luohua Ziogas, Argyrios Odegaard, Andrew O. |
author_facet | Acheampong, Teofilia Jiang, Luohua Ziogas, Argyrios Odegaard, Andrew O. |
author_sort | Acheampong, Teofilia |
collection | PubMed |
description | Multi-systemic biological risk (MSBR), a proxy for allostatic load, is a composite index of biomarkers representing dysregulation due to responses to chronic stress. This study examined the association of an MSBR index with cancer mortality. The sample included n = 13,628 adults aged 20–90 from the NHANES III Linked Mortality File (1988–1994). The MSBR index included autonomic (pulse rate, blood pressure), metabolic (HOMA(ir), triglycerides, waist circumference), and immune (white blood cell count, C-reactive protein) markers. We fit Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CI) of overall cancer mortality risk, according to quartiles (q) of the index. In multivariable models, compared to those in q1, q4 had a 64% increased risk for cancer mortality (HR = 1.64, 95% CI:1.13–2.40). The immune domain drove the association (HR per unit = 1.19, 95% CI:1.07–1.32). In stratified analyses, the HR for those with a BMI ≥ 25 was 1.12 per unit (95% CI:1.05–1.19) and those with a BMI < 25 was 1.04 per unit (95% CI:0.92–1.18). MSBR is positively associated with risk for cancer mortality in a US sample, particularly among those who are overweight or obese. The utilization of standard clinical measures comprising this index may inform population cancer prevention strategies. |
format | Online Article Text |
id | pubmed-7081240 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-70812402020-03-23 Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study Acheampong, Teofilia Jiang, Luohua Ziogas, Argyrios Odegaard, Andrew O. Sci Rep Article Multi-systemic biological risk (MSBR), a proxy for allostatic load, is a composite index of biomarkers representing dysregulation due to responses to chronic stress. This study examined the association of an MSBR index with cancer mortality. The sample included n = 13,628 adults aged 20–90 from the NHANES III Linked Mortality File (1988–1994). The MSBR index included autonomic (pulse rate, blood pressure), metabolic (HOMA(ir), triglycerides, waist circumference), and immune (white blood cell count, C-reactive protein) markers. We fit Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CI) of overall cancer mortality risk, according to quartiles (q) of the index. In multivariable models, compared to those in q1, q4 had a 64% increased risk for cancer mortality (HR = 1.64, 95% CI:1.13–2.40). The immune domain drove the association (HR per unit = 1.19, 95% CI:1.07–1.32). In stratified analyses, the HR for those with a BMI ≥ 25 was 1.12 per unit (95% CI:1.05–1.19) and those with a BMI < 25 was 1.04 per unit (95% CI:0.92–1.18). MSBR is positively associated with risk for cancer mortality in a US sample, particularly among those who are overweight or obese. The utilization of standard clinical measures comprising this index may inform population cancer prevention strategies. Nature Publishing Group UK 2020-03-19 /pmc/articles/PMC7081240/ /pubmed/32193496 http://dx.doi.org/10.1038/s41598-020-61945-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Acheampong, Teofilia Jiang, Luohua Ziogas, Argyrios Odegaard, Andrew O. Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study |
title | Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study |
title_full | Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study |
title_fullStr | Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study |
title_full_unstemmed | Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study |
title_short | Multi-Systemic Biological Risk and Cancer Mortality: The NHANES III Study |
title_sort | multi-systemic biological risk and cancer mortality: the nhanes iii study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081240/ https://www.ncbi.nlm.nih.gov/pubmed/32193496 http://dx.doi.org/10.1038/s41598-020-61945-9 |
work_keys_str_mv | AT acheampongteofilia multisystemicbiologicalriskandcancermortalitythenhanesiiistudy AT jiangluohua multisystemicbiologicalriskandcancermortalitythenhanesiiistudy AT ziogasargyrios multisystemicbiologicalriskandcancermortalitythenhanesiiistudy AT odegaardandrewo multisystemicbiologicalriskandcancermortalitythenhanesiiistudy |